Sarah Wicks Returns to HPM to Elevate Drug Development and Regulatory Practice
FDA Law Blog
MAY 1, 2024
Sarah brings a wealth of experience and a proven track record of advising innovative drug and biologics companies through the intricate landscape of product development and commercialization. Sarah’s expertise will contribute to our mission of helping drug and biologic companies navigate the pathways from discovery to commercialization.
Let's personalize your content